- Home
- ALDX vs AMPY Comparison
ALDX vs AMPY Comparison
Compare ALDX & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- AMPY
- Stock Information
- Founded
- ALDX 2004
- AMPY 2011
- Country
- ALDX United States
- AMPY United States
- Employees
- ALDX N/A
- AMPY N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- AMPY Oil & Gas Production
- Sector
- ALDX Health Care
- AMPY Energy
- Exchange
- ALDX Nasdaq
- AMPY Nasdaq
- Market Cap
- ALDX 133.7M
- AMPY 118.2M
- IPO Year
- ALDX 2014
- AMPY 2011
- Fundamental
- Price
- ALDX $2.15
- AMPY $2.87
- Analyst Decision
- ALDX Strong Buy
- AMPY Strong Buy
- Analyst Count
- ALDX 2
- AMPY 2
- Target Price
- ALDX $9.50
- AMPY $10.25
- AVG Volume (30 Days)
- ALDX 1.2M
- AMPY 690.7K
- Earning Date
- ALDX 05-14-2025
- AMPY 05-12-2025
- Dividend Yield
- ALDX N/A
- AMPY N/A
- EPS Growth
- ALDX N/A
- AMPY N/A
- EPS
- ALDX N/A
- AMPY 0.39
- Revenue
- ALDX N/A
- AMPY $290,431,100.00
- Revenue This Year
- ALDX N/A
- AMPY $6.42
- Revenue Next Year
- ALDX N/A
- AMPY $45.85
- P/E Ratio
- ALDX N/A
- AMPY $7.27
- Revenue Growth
- ALDX N/A
- AMPY N/A
- 52 Week Low
- ALDX $1.14
- AMPY $2.27
- 52 Week High
- ALDX $7.20
- AMPY $8.15
- Technical
- Relative Strength Index (RSI)
- ALDX 38.93
- AMPY 51.67
- Support Level
- ALDX $2.15
- AMPY $2.66
- Resistance Level
- ALDX $2.30
- AMPY $2.75
- Average True Range (ATR)
- ALDX 0.15
- AMPY 0.17
- MACD
- ALDX 0.06
- AMPY 0.02
- Stochastic Oscillator
- ALDX 37.93
- AMPY 41.54
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.